Acoustic droplet vaporization threshold: Effects of pulse duration and contrast agent

IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control

Volumn 54, Issue 5, 2007, Pages 933-945

  Lo, Andrea H ^a,b   Kripfgans, Oliver D ^a,b   Carson, Paul L ^a,b   Rothman, Edward D ^b   Fowlkes, J Brian ^a,b  

^a IEEE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACOUSTIC DROPLET VAPORIZATION (ADV); ACOUSTIC FREQUENCY; ALBUMIN SHELLS; INERTIAL CAVITATION; OCCLUSION THERAPY;

CAPILLARY TUBES; DROPS; HEATING; NATURAL FREQUENCIES; ONCOLOGY; VAPORIZATION;

FLUOROCARBONS;

CONTRAST MEDIUM;

ACOUSTICS; ARTICLE; ARTIFICIAL EMBOLISM; CHEMISTRY; DIFFERENTIAL THRESHOLD; GAS; METHODOLOGY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; SOLUTION AND SOLUBILITY;

ACOUSTICS; CONTRAST MEDIA; DIFFERENTIAL THRESHOLD; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBOLIZATION, THERAPEUTIC; GASES; RADIATION DOSAGE; SOLUTIONS;

EID: 34250343029     PISSN: 08853010     EISSN: None     Source Type: Journal    
DOI: 10.1109/TUFFC.2007.339     Document Type: Article

References (24)

1. T. Boehm, J. Folkman, T. Browder, and M. S. Oreilly, "Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance," Nature, vol. 390, pp. 404-407, Nov. 1997.
2. R. E. Apfel, "Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis," U.S. Patent 5 840 276, 1998.
3. J. G. Riess and M. P. Krafft, "Fluorocarbons and fluorosurfactants for in vivo oxygen transport (blood substitutes), imag ing, and drug delivery," Mater. Res. Soc., vol. 24, pp. 42-48, May 1999.
4. J. M. Correas and S. D. Quay, "EchoGen™ emulsion: A new ultrasound contrast agent based on phase shift colloids," Clin. Radiol., vol. 51, Suppl. 1, pp. 11-14, Feb. 1996.
5. O. D. Kripfgans, J. B. Fowlkes, D. L. Miller, O. Eldevik, and P. L. Carson, "Acoustic droplet vaporization for therapeutic and diagnostic applications," Ultrasound Med. Biol., vol. 26, no. 7, pp. 1177-1189, 2000.
6. O. D. Kripfgans, C. M. Orifici, P. L. Carson, K. Ives, O. P. Eldevick, and J. B. Fowlkes, "Acoustic droplet vaporization for temporal and spatial control of tissue occlusion: A kidney study," IEEE Irans. Ultrason., Ferroelect., Freq. Contr., vol. 52, pp. 1101-1110, July 2005.
7. O. D. Kripfgans, J. B. Fowlkes, M. Woydt, O. D. Eldevik, and P. Carson, "In vivo droplet vaporization for occlusion therapy and phase aberration correction," IEEE Trans. Ultrason., Ferroelect., Freq. Contr., vol. 49, pp. 726-738, June 2002.
8. T. Giesecke and K. Hynynen, "Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro," Ultrasound Med. Biol., vol. 29, no. 9, pp. 1359-1365, 2003.
9. D. L. Miller and A. Williams, "Nucleation and evolution of ultrasonic cavitation in a rotating exposure chamber," J. Ultrasound Med., vol. 11, no. 8, pp. 407-412, 1992.
10. J. E. Parsons, C. A. Cain, and J. B. Fowlkes, "Cost-effective assembly of a basic fiber- optic hydrophone for measurement of high-amplitude therapeutic ultrasound fields," J. Acoust. Soc. Amer., vol. 119, no. 3, pp. 1432-1440, 2006.
11. P. A. Dayton, K. E. Morgan, A. L. Klibanov, G. Brandenburger, K. R. Nightingale, and K. W. Ferrara, "A preliminary evaluation of the effects of primary and secondary radiation forces on acoustic contrast agents," IEEE Trans. Ultrason., Ferroelect., Freq. Contr., vol. 44, pp. 1264-1277, Nov. 1997.
12. W. Chen, A. A. Brayman, T. J. Matula, and L. Crum, "Inertial cavitation dose and hemolysis produced in vitro with or without Optison®," Ultrasound Med. Biol., vol. 29, no. 5, pp. 725-737, 2003.
13. E. Everbach, I. Makin, M. Azadniv, and R. Meltzer, "Correlation of ultrasound-induced hemolysis with cavitation detector output in vitro," Ultrasound Med. Biol., vol. 23, no. 4, pp. 619-624, 1997.
14. F. A. Duck, Physical Properties of Tissue: A Comprehensive Reference Book. London: Academic, 1990, pp. 95-98.
15. T. L. Szabo, F. Clougherty, and C. Grossman, "Effects of nonlinearity on the estimation of in situ values of acoustic output parameters," J. Ultrasound Med., vol. 18, pp. 33-41, Jan. 1999.
16. C. Holland and R. Apfel, "Thresholds for transient cavitation produced by pulsed ultrasound in a controlled nuclei environment," J. Acoust. Soc. Amer., vol. 88, pp. 2059-2069, Nov. 1990.
17. D. Miller and R. Thomas, "Ultrasound contrast agents nucleate inertial cavitation in-vitro," Ultrasound Med. Biol., vol. 21, no. 8, pp. 1059-1065, 1995.
18. P. Chang, W. Chen, P. D. Mourad, S. Poliachik, and L. Crum, "Thresholds for inertial cavitation in albunex suspensions under pulsed ultrasound conditions," IEEE Trans. Ultrason., Ferroelect., Freq. Contr., vol. 48, pp. 161-170, Jan. 2001.
19. S. Chen, M. H. Kroll, R. V. Shohet, P. Frenkel, S. A. Mayer, and P. A. Grayburn, "Bioeffects of myocardial contrast microbubble destruction by echocardiography," Echocardiography: J. CV Ultrasound Allied. Tech., vol. 19, pp. 495-500, Aug. 2002.
20. P. Li, W. F. Armstrong, and D. L. Miller, "Impact of myocardial contrast echocardiograph on vascular permeability: Comparison of three different contrast agents," Ultrasound Med. Biol., vol. 30, no. 1, pp. 83-91, 2004.
21. G. Iernetti, "Cavitation threshold dependence on volume," Acustica, vol. 24, no. 4, pp. 191-196, 1971.
22. N. de Jong, L. Hoff, T. Skotland, and N. Bom, "Absorption and scatter of encapsulated gas filled microspheres: Theoretical considerations and some measurements," Ultrasonics, vol. 30, pp. 95-103, Mar. 1992.
23. C. C. Church, "The effects of an elastic solid-surface layer on the radial pulsations of gas bubbles," J. Acoust. Soc. Amer., vol. 97, pp. 1510-1521, Mar. 1995.
24. R. M. Berne and M. N. Levy, Physiology. 3rd ed. St. Louis, MO: Mosby-Year Book, 1993, p. 555.